On 11.02.2019, the Chief Pharmaceutical Inspector issued a decision to temporarily prohibit placing on the market and withhold the trade of all medicinal products containing the active substance fenspiride hydrochloride (Fenspiridi hydrochloridum) across the country, this including:

• Pulneo (Fenspiridi hydrochloridum) oral drops, solution 15 ml and 30 ml;
• Pulneo (Fenspiridi hydrochloridum) cola-flavored syrup 150 ml;
• Pulneo (Fenspiridi hydrochloridum) syrup 150 ml.

The above applies until the end of the explanatory procedure.